Introduction
Mental disorders are very common in epilepsy and may even precede the onset of seizures. Studies have shown a high prevalence of epilepsy in individuals with mental disorders, suggesting an association between the two conditions. [1] [2] [3] Such connection was observed in a recent epidemiological study in a psychiatric hospital where 10% of the inpatients had epilepsy. 1 Further, several other studies report a high prevalence of psychiatric disorders in people with epilepsy. [4] [5] [6] Despite the lack of epidemiologic data in Brazil, it is estimated that there is something between 530 thousand and 890 thousand people with epilepsy and some associated mental disorders in this country. 7 Temporal lobe epilepsy (TLE) encompasses epileptic syndromes that arise in the temporal lobes and mesial temporal lobe epilepsy (MTLE), the main subtype of TLE, is probably the commonest presentation of epilepsy in humans. [8] [9] [10] MTLE is frequently associated with a poor seizure response to antiepileptic drugs (AEDs), especially if mesial temporal sclerosis (MTS) is present. 9, 11 MTLE is also called limbic epilepsy and the latter term has been preferred by many authors because it reinforces the idea of a system involvement rather than specific structures. 10 In addition, studies have emphasized that patients with TLE present a high propensity to develop psychiatric disorders due to the role of the limbic system in regulating emotions, mood and behavior. [12] [13] [14] [15] It should be noted that it is difficult to establish precisely the frequency of psychiatric disorders in epilepsy, as mental phenomena may result from a complex interaction between neurophysiologic changes caused by seizures, AEDs side effects, individual vulnera-bility and subjective experience of psychosocial impact. 6, [16] [17] [18] It is, therefore, challenging to diagnose, treat, minimize functional impairment and improve quality of life of these patients. 2 In this study we conducted a psychiatric survey in a group of TLE patients in a tertiary-care service in Brazil and we describe and correlate their psychopathological, sociodemographic and clinical characteristics.
Methods
A cross-sectional study was conducted with 73 TLE patients. All subjects were monitored by the Epilepsy Clinic of the Neurology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), which is a regional reference service for refractory epilepsy treatment. This service encompasses around 1000 patients that are referred from general practitioners, general physicians, or general neurologists of the whole state of Minas Gerais due to difficult control of seizures. This study was approved by the local Ethics Committee (according to the Declaration of Helsinki). The inclusion criteria were: diagnosis of TLE according to the ILAE criteria, 8 age more than 18 years and capacity to provide written informed consent for participation in the study. Patients were excluded if they had severe medical or neurologic disease other than epilepsy, history of previous neurosurgery, and severe cognitive impairment according to MMSE performance.
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Sociodemographic (age, gender, ethnicity, marital status, employment situation and educational level) and clinical information (age at onset and duration of the epilepsy, seizure type, seizure frequency, refractory epilepsy according to ILAE criteria, 20 antiepileptic drug regime, MRI and EEG findings) were collected.
Psychiatric diagnosis was made according to the Mini International Neuropsychiatric Interview (MINI) Plus version 5.0.0. The MINI-PLUS is an internationally validated standardized interview frequently used in clinical and research contexts, following DSM-IV and ICD-10 criteria. [21] [22] [23] Algorithms are integrated into the structure of the questionnaire and they allow hierarchical diagnosis as well as psychiatric comorbidities in the same patient. 21 For psychiatric diagnosis the recommendations of ILAE Commission on Psychobiology of Epilepsy were also followed in order to conduct a more descriptive classification, correlating clinical variables (e.g., ictal and interictal symptoms, relationship with AEDs therapy, etc.) and avoiding pre-setting all cases with an ''organic'' etiologic label. 24, 25 Patients who met diagnostic criteria for clinically significant mental disorders were referred for psychiatric treatment. Anxiety symptoms were assessed using the Hamilton Anxiety Scale (HAM-A) (total score range: 0-56). 24, 26, 27 Hamilton Depression Scale (HAM-D) 24, 28, 29 was used to measure depressive symptoms. We used the 24-item HAM-D (total score range: 0-75), which includes helplessness, hopelessness and low self-esteem items, 29 in order to reduce the weight of the somatic symptoms, increasing its specificity. The 18-item Brief Psychiatric Rating Scale (BPRS) (total score range: 0-108) was used to quantify psychotic and general psychopathology. 30, 31 Descriptive analysis of categorical variables and proportions were calculated and presented. For comparison of categorical variables between groups Fisher's Exact test was performed and continuous variables were evaluated using the Kruskal-Wallis test. All tests were performed using SPSS version 15.0 for Windows. A lower than 0.05 two-sided p-value was considered significant for all tests.
Results

Clinical and sociodemographic characteristics
Seventy-three patients were included in this study. The sociodemographic and clinical characteristics of patients with TLE are displayed in Table 1 .
Patients had a mean of 4.8 seizures per month, usually with childhood onset (mean age 8.5 years) and long time course (mean 33.7 years). A combination of focal seizures types was observed as 95.9% exhibited complex partial, 42.5% had simple partial seizures and secondarily generalization was reported in 28 individuals (38.4%). It is worth noting the impairment on working capacity where less than half (42.5%) of the patients were employed.
Most of the patients (64.4%) were on two AEDs. Carbamazepine (64.4%) in monotherapy or in association with other drugs was the most prescribed AED alone; benzodiazepines (72.6%) were the most common pharmacological group.
Refractoriness was characterized in the majority of patients (80.8%) and only a few had achieved seizure control for more than six months. Table 2 lists the neuropsychiatric comorbidities demonstrating the high frequency of lifetime psychiatric disorders (69.9%), especially mood disorders (49.3%).
Psychiatric characteristics
Only one patient (6.3%) diagnosed with major depressive disorder was taking antidepressants and scored 33 on the HAM-D.
It was possible to identify ictal and perictal psychotic symptoms in only one patient. This patient also met criteria for the diagnosis of schizophrenia due to the interictal psychotic state (BPRS = 28). Only one other patient in the psychotic group, diagnosed with schizophrenia, was on antipsychotic medication (risperidone 4 mg/d) and presented mild psychotic symptoms (BPRS = 30). The other patient diagnosed with schizophrenia diagnosis scored 47 points in the BPRS and the one with psychosis NOS, 8 points.
There were no significant differences regarding refractoriness and the presence of any mental disorder.
Characteristics and frequency of psychiatric disorders according to mesial temporal sclerosis
Patients were divided in four groups: 25 patients with right MTS (RMTS), 30 with left MTS (LMTS), 8 with bitemporal MTS (BMTS) and 10 without MTS (WMTS). Groups were statistically different regarding gender (p = 0.043), as there were only two (20%) women in the WMTS group, and according to the duration of epilepsy (p = 0.047), as the WMTS group had also a shorter duration of epilepsy. There were no other significant differences on sociodemographic and clinical variables as displayed in Table 3 .
Patients with LMTS had a higher frequency of mood and anxiety disorders, though only anxiety disorders reach statistical significance (p = 0.006) when all groups were compared. Higher scores on HAM-A and HAM-D (p < 0.05 in both) were also linked to LMTS ( Table 4 ). The group with BMTS had an eminent higher frequency of psychosis (25%) when compared to the other groups (<5%), though this difference did not reach statistical significance (p = 0.14), as shown in Table 4 . In addition, both groups with BMTS and LMTS presented high scores in BPRS (p = 0.06).
Discussion
This study describes a cross-sectional observation of the neuropsychiatric profile of patients with TLE seen in a tertiarycare service. The assessment of mental state in epilepsy should consider that the internationally accepted systems of classification in psychiatry, ICD-10 and DSM-IV, tend to label the neuropsychiatric comorbidities in epilepsy as ''organic'' or ''due to medical conditions''. However, most experts on this subject agree that such systems are clearly superficial and overlook the neuropsychiatry diversity found in epilepsy. 32, 33 For this reason, the present study addresses the recent proposal by the ILAE Commission on Psychobiology of Epilepsy 33,34 since the diagnosis was based in a psychopathological description that also tried to consider clinical variables related to epilepsy. The population in the study consisted of relatively young patients, with childhood onset seizures, without complete remission despite the fact that the majority of patients was taking more than one AED. In these patients, TLE compromised significantly labour functioning as a large number of individuals were receiving illness welfare benefits.
The present study highlights the high frequency of lifetime mental disorders in TLE, especially depression and anxiety. It is worth pointing out that it is not unusual to see the coexistence of mood and anxiety disorders in the same individual, with or without epilepsy. 3 Depression is considered the most common mental disorder in people with epilepsy, 35 as is evidenced in this sample, where more than one-third of patients had a major depressive disorder during their lives and a significant number of patients were depressed when evaluated. These data show an increase in prevalence of major depression or any mood disorder over the general population without epilepsy, whose lifetime prevalence rates are around 11% and 13%, respectively. 4 The underdiagnosis and undertreatment of depression highlighted by this study are not new in literature, but underline its persistence despite several warnings from specialists on the topic. 3, 32, 36 We can infer from the results that none of the evaluated patients with current major depression were receiving psychiatric treatment. The only patient taking antidepressants was actually being treated for migraine (25 mg amitriptyline), whose therapeutic dose is below that recommended for depression, 37 and still showed significant depressive symptoms. Most studies evaluating mood disorders in epilepsy focus on depressive disorders and information regarding bipolar disorder (BD) in this population is still limited. 38 BD was diagnosed in about 10% of the patients, which is consistent with a recent publication that found BD in 11.8% of a total of 143 epileptic patients, most of them with TLE. 23 However, these authors draw attention to the role of Interictal Dysphoric Disorder (IDD), AEDs and perictal phenomena producing phenotypic copies of BD. 39 By removing these confounding factors, the authors describe a frequency of 1.4% of ''pure bipolar'', arguing that the ''pure'' BD frequency in epilepsy is similar to the one found in general population. 23 Although some patients have reported perictal manic and hypomanic episodes in the present study, this information has limited value because selfreports are often inaccurate due to common memory impairment and this is one of the limitations of this cross-sectional study. One proposal would include a more detailed longitudinal assessment with seizure and mood calendars. 23 Anxiety and depression have close overlap in clinical practice 40, 41 which might reflect common pathogenic mechanisms shared with epilepsy comprising limbic structures. 22, 42, 43 Tebartz van Elst et al. 44 described increased amygdala volume in TLE patients with dysthymia and additionally pointed out that depressive symptoms positively correlated to the left amygdala volume. 44, 45 A greater volume of the right amygdala was reported in a group of eight patients with partial refractory epilepsy and comorbid anxiety when compared to a group of eight patients with epilepsy but no psychopathology. 46 Paparrigopoulos et al. 43 analyzed mesial structures volume after lobectomy for epilepsy and observed that right side hippocampus volumes positively correlated to depressive symptoms in patients who underwent left-side resections and that anxiety symptoms were negatively correlated to the residual left hippocampal volume. They hypothesized that right-left hippocampal asymmetry can influence mood regulation yielding higher rates of depressive and anxiety symptoms, at least in LMTS. 43 Interestingly, Bear and Fedio 47 described that patients with left TLE tended to exaggerate their depressive complaints on selfreports while patients with right TLE minimized them. Altshuler et al. 48 also found that patients with left TLE scored higher on selfratings for depression. It is possible that a personality trait may be a confounding factor but this was minimized as the psychopathological assessment used here was based on observer-rated instruments. In the present study, the diagnosis of anxiety disorders were more likely to occur in patients with LMTS (p = 0.006) that also had higher scores on HAM-A (p = 0.012) and on HAM-D (p = 0.03) too. These data are in line with the literature that reports that anxiety disorders are associated with functional impairment in left limbic structures [49] [50] [51] that can also be linked to the coexistence of depressive symptoms. 48, 49 However, the etiology of mental disorders in epilepsy is probably multifactorial in which neurobiological and psychosocial variables interact. In this direction, it should be commented that the groups with MTS, especially LMTS, where the ones with lengthier disease. Long duration epilepsy may be associated with constant uncertainty created by refractory seizures, fear and social restriction which are psychosocial risk factors for anxiety disorders. 46 Additionally, limbic structures are associated with the genesis of epilepsy, anxiety and depression what makes this association also relevant from a neurobiological perspective. 3, 40 On the other hand, studies have shown that a shorter duration of epilepsy was associated with depression 52, 53 and other psychiatric conditions, emphasizing the difficulties of coping with a new medical problem. 54 Hence, it seems appropriate to consider the duration of seizure disorder when interpreting psychiatric comorbidity in epilepsy. Psychotic disorders were diagnosed in 5.5% of the sample, a percentage lower than that described in the literature which suggests that the prevalence of psychosis in TLE is around 19%. 13, 16, 55 The explanations for this may include methodological differences, outpatients profile and the sample size. It is also possible that some psychotic patients were excluded due to low MMSE scores as often psychotic syndromes are associated with severe cognitive impairments. 56 The discussion around laterality and psychotic manifestations was inaugurated by the seminal work of Flor-Henry. 57 62 who evaluated temporolimbic structural abnormalities in schizophrenia, indicate a link between bilateral hippocampal atrophy to a more severe and refractory psychosis. In the present study, though not statistically significant, it is possible to discern an increased frequency of psychotic disorders in the BMTS group in agreement with the aforementioned studies that support a bitemporal involvement in psychosis.
The present study has some clear limitations, such as the sample size consisting of severely ill patients and also the lack of control groups. Conversely, an important strength of this study is the broad psychiatric assessment which allows accurate psychopathological description.
Future research must contemplate follow-up studies attentive to treatment and prognosis. As most of the studies were conducted in specialized centers, primary care studies in developing countries are needed to show the current status of the problem in the community as well. Another important point to investigate is the outcome of the patients who will undergo epilepsy surgery. Moreover, forthcoming studies shall take into account the ILAE recommendations on the diagnosis of mental disorders in epilepsy. Considering these observations, the present study can encourage proposals to include specific classification of epilepsy mental disorders on the newer versions of psychiatric manuals, such as the DSM-5, which is being formulated. Finally, it is also possible that there was an overdiagnosis of anxiety, bipolar and OCD due to the psychopathological instruments used here, as there is no gold standard assessment instrument to neuropsychiatric diagnosis in epilepsy. On the other hand, the methods used in the present study are consistent to the ones proposed by ILAE experts and have practical implications as a reference for clinical interventions. 24, 33 In any event, in trying to improve epilepsy treatment and quality of life it is important to listen carefully to the patients complaints and not only diagnose but also treat properly psychiatric comorbidities. Kanner 63 argues that patients should be referred for psychiatric treatment as if the following are suspected: a diagnosis of bipolar disorder, depression with psychotic symptoms, any mood disorder with suicidal ideation or major depression that persists after two trials of antidepressants.
Conclusion
More efforts are needed in order to improve recognition of neuropsychiatric comorbidity and its treatment. Psychiatric disorders are commonly neglected in epilepsy and new clinical instruments may help elucidating psychopathological features commonly described in the epilepsy context. Patients with LMTS are more susceptible to psychiatric conditions, such as anxiety disorders, while psychosis may show a special correlation with bilateral damage in mesial temporal lobes.
The investigation of the neuropsychiatric aspects of TLE should direct the development of programs to improve the management of the common mental disorders that accompany this epileptic syndrome. Therefore, we hope that this study contributes to the discussion and reinforces the need to identify what often goes unnoticed in many TLE patients with mental disorders in Brazil.
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